You must have been treated with pegylated interferon (brand names are Pegasys® or Peg-Intron®) and ribavirin (brand names Rebetol® or Copegus®), for at least 12 weeks. However, you cannot have received more than one course of this combination therapy. [clinicaltrials_resource:4479287d45b16a4d65556d32f3ac9fdd]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
You must have been treated with pegylated interferon (brand names are Pegasys® or Peg-Intron®) and ribavirin (brand names Rebetol® or Copegus®), for at least 12 weeks. However, you cannot have received more than one course of this combination therapy. [clinicaltrials_resource:4479287d45b16a4d65556d32f3ac9fdd]
Bio2RDF identifier
4479287d45b16a4d65556d32f3ac9fdd
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:4479287d45b16a4d65556d32f3ac9fdd
identifier
clinicaltrials_resource:4479287d45b16a4d65556d32f3ac9fdd
title
You must have been treated wit ...... e of this combination therapy.
@en
type
label
You must have been treated wit ...... 9287d45b16a4d65556d32f3ac9fdd]
@en